Proteomics International Laboratories Ltd
ASX:PIQ
Balance Sheet
Balance Sheet Decomposition
Proteomics International Laboratories Ltd
Current Assets | 5.2m |
Cash & Short-Term Investments | 5m |
Receivables | 76.7k |
Other Current Assets | 129.6k |
Non-Current Assets | 1.8m |
PP&E | 1.8m |
Intangibles | 1k |
Current Liabilities | 1.2m |
Accounts Payable | 387.2k |
Other Current Liabilities | 806.7k |
Non-Current Liabilities | 401.3k |
Long-Term Debt | 11k |
Other Non-Current Liabilities | 390.3k |
Balance Sheet
Proteomics International Laboratories Ltd
Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
0
|
2
|
1
|
1
|
2
|
2
|
2
|
6
|
2
|
6
|
|
Cash |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
0
|
|
Cash Equivalents |
0
|
2
|
1
|
1
|
2
|
1
|
0
|
5
|
1
|
6
|
|
Total Receivables |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
|
Accounts Receivables |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Assets |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
|
Total Current Assets |
0
|
3
|
2
|
2
|
4
|
3
|
4
|
7
|
4
|
8
|
|
PP&E Net |
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
1
|
2
|
|
PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
|
Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
|
Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Long-Term Investments |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Assets |
0
N/A
|
3
+549%
|
2
-36%
|
3
+78%
|
5
+90%
|
4
-34%
|
6
+53%
|
9
+55%
|
5
-37%
|
10
+87%
|
|
Liabilities | |||||||||||
Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
Total Current Liabilities |
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
|
Long-Term Debt |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
Total Liabilities |
1
N/A
|
1
-44%
|
1
+14%
|
1
+54%
|
1
-36%
|
1
-22%
|
1
+76%
|
1
-11%
|
2
+102%
|
2
-15%
|
|
Equity | |||||||||||
Common Stock |
0
|
4
|
4
|
6
|
10
|
11
|
13
|
19
|
19
|
30
|
|
Retained Earnings |
1
|
2
|
3
|
4
|
6
|
8
|
9
|
11
|
16
|
22
|
|
Total Equity |
1
N/A
|
2
N/A
|
1
-56%
|
2
+103%
|
5
+190%
|
3
-36%
|
4
+49%
|
8
+71%
|
3
-55%
|
8
+147%
|
|
Total Liabilities & Equity |
0
N/A
|
3
+549%
|
2
-36%
|
3
+78%
|
5
+90%
|
4
-34%
|
6
+53%
|
9
+55%
|
5
-37%
|
10
+87%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
65
|
51
|
51
|
59
|
80
|
81
|
92
|
105
|
106
|
121
|